What is our outlook on Oric PharmaceuticalsI (USA Stocks:ORIC) and HIGH-YIELD (USA Stocks:ABHYX)?
 | By Raphi Shpitalnik | Macroaxis Story |
As many rational traders are trying to avoid healthcare space, it makes sense to go over Oric PharmaceuticalsInc a little further and understand how it stands against HIGH-YIELD MUNICIPAL and other similar entities. We are going to analyze some of the competitive aspects of both Oric PharmaceuticalsI and HIGH-YIELD.
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Michael Smolkin
By analyzing existing forward indicators between Oric PharmaceuticalsI and HIGH-YIELD, you can compare the effects of market volatilities on both companies' prices and check if they can diversify away market risk if combined in one of your portfolios. You can also utilize pair trading strategies for matching a long position in HIGH-YIELD with a short position in Oric PharmaceuticalsI. Check out our pair correlation module for more information.
Let's begin by analyzing the assets.
Let's begin by analyzing the assets.
One of the ways to look at asset utilization of Oric PharmaceuticalsI is to check how much profit was generated for every dollar of assets it reports. Oric PharmaceuticalsI holds a negative application of assets of -0.2 pct., losing $0.00198 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Oric PharmaceuticalsInc shows how discouraging it operates for each dollar spent on its assets.
Out of tens of thousands of stocks, funds, and ETFs that trade on global exchanges each represent an individual company which you can analyze using comparative analysis. To determine which one of the two entities, such as Oric or Cullinan is a better fit for your portfolio, analyzing a few basic fundamental indicators is a good first step. 
How important is Oric PharmaceuticalsI's Liquidity
Oric PharmaceuticalsI financial leverage refers to using borrowed capital as a funding source to finance Oric PharmaceuticalsInc ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Oric PharmaceuticalsI financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Oric PharmaceuticalsI's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Oric PharmaceuticalsI's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between Oric PharmaceuticalsI's total debt and its cash.
Correlation Between Oric and Cullinan Oncology LLC
In general, Stock analysis is a method for investors and traders to make individual buying and selling decisions. Stock correlation analysis is also essential because it can help investors realize that they may not be as diversified as they think. Risk management strategies are usually required to make sure all portfolios are properly aligned against their risk tolerance level. You can consider holding Oric PharmaceuticalsI together with similar or unrelated positions with a negative correlation. For example, you can also add Cullinan Oncology to your portfolio. If Cullinan Oncology is not perfectly correlated to Oric PharmaceuticalsI it will diversify some of the market risks out of the positively correlated stocks in your portfolio. However, the disadvantage of this sort of hedging is that it can potentially affect your investment returns throughout market cycles. When Oric PharmaceuticalsI, for example, performs excellent and delivers stable returns, the negatively correlated position you locked in as a hedge may drag your returns down.
Are you currently holding both Oric PharmaceuticalsI and Cullinan Oncology in your portfolio? Please note if you are using this as a pair-trade strategy between Oric PharmaceuticalsI and Cullinan Oncology, watch out for correlation discrepancy over time. Relying on the historical price correlations and assuming that it will not change may lead to short-term losses. Please check pair correlation details between ORIC and CGEM for more information.Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Oric PharmaceuticalsInc. Please refer to our Terms of Use for any information regarding our disclosure principles.